‘Gujarat Kidney and Super Speciality Limited’ is a Multispeciality Company Providing Healthcare Services at Several Locations in Gujarat

The company operates seven multispeciality hospitals and four pharmacies, with a total bed capacity of 490, an approved capacity of 455 beds, and an operational capacity of 340 beds.

bolt Latest News Updates for You

Yuthika Professional Relaunches Moroccan Argan Oil for Advanced Salon Care and Hair Treatment

NEW

AutoSoft Training and Solutions Announces Advanced Learning Programs in CAD, Automotive Product Design and Embedded Systems

What to Do If Your Online Bank Account Opening Fails: Common Errors and Solutions

The company’s hospitals include Gujarat Kidney and Super Speciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Pamland Hospital Private Limited (Bharuch), Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Center (Anand). The company also operates Ashwini Medical Store (Anand).

Company services

• Secondary care services: General and surgical treatments.
• Tertiary care services: Super-speciality surgical procedures.

Gujarat Super Speciality Hospital provides medical care in areas such as internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma care, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology. As of June 30, 2025, the company employed 89 doctors, 332 nurses, and 338 other staff members.

Also Read

AutoSoft Training and Solutions Announces Advanced Learning Programs in CAD, Automotive Product Design Business

Financial performance: In the financial year 2024, the company earned total revenue of Rs 5.48 crore and a profit after tax of Rs 1.71 crore, and in the financial year 2025, the company earned total revenue of Rs 40.40 crore and a profit after tax of Rs 9.50 crore. In the period ended June 30, 2025, of the financial year 2026, the company earned total revenue of Rs 15.27 crore and a profit after tax of Rs 5.40 crore. The financial results clearly indicate that the company’s revenue and profit are increasing year on year. In the period ended June 30, 2025, of the financial year 2026, the company achieved a profit after tax margin of 35.41 per cent.

Information regarding the IPO: The IPO of Gujarat Kidney and Super Speciality Limited will open on December 22, 2025 and close on December 24, 2025, on the BSE and NSE mainboards. The company is issuing up to 2,20,00,000 shares of face value Rs 2 each. The IPO is being managed by the Book Running Lead Manager (BRLM), Nirbhay Capital Services Private Limited.

Note: This article is not investment advice.